optic neuritis glp 1 NAION and GLP1s: Rare Cause of Blindness Linked to Medication | Michael Weintraub, MD posted on the topic Global Study Links GLP-1 Drugs

Imagine if we spent as much energy predicting risk as we do managing complications

The therapeutic efficacy of GLP-1RAs is underscored by their ability to significantly lower glycated hemoglobin (HbA1c) levels, with reductions ranging from 0.42% to 1.6% depending on the formulation and duration of treatment

Designed for daily use the 5-layer synbiotic works with your gut and microbiome to support digestive function, nutrient absorption, and metabolic health.* Digestive Support Activates Bloating and digestive discomfort start to quiet down

Metabolic benefits at low doses Even at microdose levels, GLP-1R agonists improve glucose variability, reducing post-meal blood glucose spikes

This new information has left many patients wondering if these novel miracle drugs are safe to use